Comparison of two pharmaceutical products containing ferrous sulfate using Mössbauer spectroscopy
Hyperfine Interactions, ISSN: 1572-9540, Vol: 244, Issue: 1
2023
- 1Citations
- 1Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Two fresh commercial pharmaceutical products containing ferrous sulfate such as Tardyferon® and Fenules® were studied by X-ray diffraction and Mössbauer spectroscopy. The obtained results demonstrated that each product contains iron compounds assigned to (i) FeSO × HO and FeSO × 4HO in Tardyferon® and probably two FeSO × HO compounds with some tiny variations in the iron local microenvironments in Fenules®, and (ii) one ferric compound which was unidentified for Tardyferon® but identified as ferric acidic iron sulfate for Fenules®. A water free ferrous sulfate declared by the manufacturer was not found in Fenules®.
Bibliographic Details
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know